Diagnamed Holdings Corp.

CNSX:DMED Stock Report

Market Cap: CA$3.2m

Diagnamed Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Fabio Chianelli

Chief executive officer

CA$180.0k

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownership9.2%
Management average tenureno data
Board average tenure2.5yrs

Recent management updates

Recent updates


CEO

Fabio Chianelli (45 yo)

2.8yrs

Tenure

CA$180,000

Compensation

Mr. Fabio Chianelli is the Founder of PharmaTher Holdings Ltd. (formerly known as Newscope Capital Corporation) (formerly known as PharmaTher Inc.). and serves as its Chief Executive Officer since June 03,...


Board Members

NamePositionTenureCompensationOwnership
Fabio Chianelli
Chairman2.8yrsCA$180.00k9.2%
CA$ 294.7k
Ming Jang
Independent Director2.3yrsno datano data
Elyssia Patterson
Independent Director3.1yrsno data0.13%
CA$ 4.1k
Carlo Sansalone
Independent Non-Executive Director1.3yrsno data2.5%
CA$ 80.0k

2.5yrs

Average Tenure

45yo

Average Age

Experienced Board: DMED's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.